ArticleAmerican journal of translational research2025
Left atrial stiffness index predicts atrial fibrillation risk in heart failure with preserved ejection fraction: a nomogram model.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDevelop a LASI-based nomogram for predicting atrial fibrillation (AF) risk in heart failure with preserved ejection fraction (HFpEF).
methodsThis retrospective study analyzed 275 HFpEF patients (160 AF, 115 controls). Echocardiography measured LASI (E/e' divided by peak atrial longitudinal strain), left atrial volumes, strains (AP2%, AP4%), and electromechanical delays (SD2: inter-atrial; SD4: intra-left atrial). Multivariate logistic regression identified AF predictors. Nomogram performance was validated by ROC analysis and DCA.
resultsCompared to controls, the AF group had significantly larger LVDD/LVSD (P<0.001 both), lower 3D-LAEF% (P<0.001), lower E/e' (P<0.001), higher LASI (P<0.001), larger BSA (P<0.001), higher AP2% (P<0.001), lower AP4% (P<0.001), and longer SD4 (P<0.001). Multivariate analysis identified positive associations with AF risk for: BSA (OR=9.167, P<0.001), AP4% (OR=1.033, P=0.008), SD2 (OR=1.003, P=0.001), and LASI (OR=1.043, P<0.001). Negative associations were found for E/e' (OR=0.889, P=0.002) and SD4 (OR=0.997, P<0.001). ROC AUCs were: LASI=0.666, E/e'=0.707, BSA=0.682, SD2=0.615, AP4=0.666, SD4=0.705. The combined model AUC was 0.801. DCA identified LASI as the optimal single predictor (net benefit 0.3184).
conclusionLASI independently predicted AF risk in HFpEF. The validated nomogram, integrating LASI, BSA, and electromechanical markers (SD2, SD4, AP4%, E/e'), enables precise AF risk stratification, aiding early identification of high-risk patients for targeted intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.